CIK 0001035354
- Non-accelerated filer
- Smaller reporting company
Eloxx Pharmaceuticals, Inc.
Sign in to watch- Ticker
- ELOX
- Exchange
- Nasdaq
- Industry
- Biological Products, (No Diagnostic Substances)
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- EIN
- 841368850
- Phone
- +1 781-577-5300
- Business address
- P.O. BOX 274, ARLINGTON, MA, 02476
- Former names
- Sevion Therapeutics, Inc., SENESCO TECHNOLOGIES INC, NAVA LEISURE USA INC
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2015-11-19 | FROST PHILLIP MD ET AL Director | Grant or award · Company Stock Option | +32,500 | $0.25 | $8K | 32,500 |
| 2015-11-19 | Waksal Harlan Director | Grant or award · Company Stock Option | +40,000 | $0.25 | $10K | 40,000 |
| 2015-11-19 | BRACA JOHN N Director | Grant or award · Company Stock Option | +42,500 | $0.25 | $11K | 42,500 |
| 2015-09-29 | FROST PHILLIP MD ET AL Director | Purchase | +35,000 | $0.61 | $21K | 1,598,170 |
| 2015-05-18 | Waksal Harlan Director | Grant or award · Common Stock Option | +11,340 | $0.97 | $11K | 147,693 |
| 2015-02-19 | Waksal Harlan Director | Grant or award · Common Stock Option | +26,552 | $0.54 | $14K | 136,353 |
| 2014-11-18 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Option (right to buy) | +27,882 | 64,107 | ||
| 2014-11-18 | FORBES CHRISTOPHER Director | Grant or award · Common Stock Option (right to buy) | +3,462 | $0.42 | $1K | 67,569 |
| 2014-11-18 | THOMPSON JOHN PHD Scientific Founder | Grant or award · Common Stock Option (right to buy) | +34,020 | 53,391 | ||
| 2014-11-18 | SMIDER VAUGHN Chief Scientific Officer | Grant or award · Common Stock Option (right to buy) | +42,210 | 42,210 | ||
| 2014-11-18 | MARTELL RON Chief Executive Officer | Grant or award · Common Stock Option (right to buy) | +56,364 | 456,364 | ||
| 2014-11-18 | Waksal Harlan Director | Grant or award · Common Stock Option (right to buy) | +38,034 | 92,332 | ||
| 2014-11-18 | Waksal Harlan Director | Grant or award · Common Stock Option (right to buy) | +17,168 | $0.42 | $7K | 109,500 |
| 2014-11-18 | Browne Leslie J President | Grant or award · Common Stock Option (right to buy) | +42,210 | 82,065 | ||
| 2014-11-18 | Rubin Steven D Director | Grant or award · Common Stock Option (right to buy) | +25,344 | 25,344 | ||
| 2014-11-18 | Rubin Steven D Director | Grant or award · Common Stock Option (right to buy) | +3,314 | $0.42 | $1K | 28,658 |
| 2014-11-18 | RECTOR DAVID Director | Grant or award · Common Stock Option (right to buy) | +31,698 | 73,380 | ||
| 2014-11-18 | RECTOR DAVID Director | Grant or award · Common Stock Option (right to buy) | +5,270 | $0.42 | $2K | 78,650 |
| 2014-11-18 | FROST PHILLIP MD ET AL Director | Grant or award · Common Stock Option (right to buy) | +25,344 | 25,344 | ||
| 2014-11-18 | Dondero Richard S VP - Preclinical Research | Grant or award · Common Stock Option (right to buy) | +28,140 | 49,476 |
Page 18 of 20 · 388 trades